论文信息 - Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells. - 字舞流文

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells.

M. Carroll | S. Grupp | D. Porter | M. Kalos | C. June | M. Ruella | O. Shestova | G. Danet-Desnoyers | S. Gill | S. Tasian | J. Scholler | Yong Li